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and Young Children with
AchromatopsiaNormally, postnatal development of the human retina involves
centrifugal displacement of the inner retinal layers (IRLs) from the
fovea, centripetal migration of the cone photoreceptors into the
fovea, and elongation of the photoreceptors with age.1,2 It is not
clear whether retinal development in infants and young children
with achromatopsia (ACHM) occurs in a similar way and whether
any retinal changes that occur are progressive in early childhood.
To answer this question, we undertook a longitudinal optical
coherence tomography (OCT) study of in vivo foveal development
in a cohort of 10 children with a conﬁrmed genetic diagnosis of
ACHM (Table 1, available at www.aaojournal.org). The study
adhered to the tenets of the Declaration of Helsinki and was
approved by the local ethic committee. Volumetric foveal scans
of the foveal region were obtained using the Bioptigen handheld
spectral domain OCT as previously described.3 Each retinal layer
was segmented using ImageJ software (available at:
www.rsbweb.nih.gov/ij; accessed May 11, 2012). Longitudinal
data were available for 7 of the 10 children with ACHM, with a
mean follow-up time of 18.9 months (range, 5.3e35.5). A total
of 55 cross-sectional (n ¼ 6) and longitudinal (n ¼ 49) examina-
tions were obtained. These were compared with 110 cross-sectional
examinations obtained from 59 age-, gender-, and race-matched
controls. The mean age at the time of examination was 40.6
months (range, 2.4e98.7) for the ACHM group and 40.6 months
(range, 1.4e120.9) for the control group.
In all of the participants with ACHM, there was evidence of
foveal hypoplasia (presence of the normally absent IRLs at the
fovea) at each visit on OCT examination. A delay in migration of
the photoreceptors into the central fovea was evident in the
youngest ACHM participants. There was evidence of photore-
ceptor disruption (consisting of ellipsoid [ISe] disruption and/or a
hyporeﬂective zone) in the ACHM group, the severity of which
was graded using a modiﬁed version of a previously described
grading system4 (Fig 1; Table 1, available at www.aaojournal.org).
We assessed for changes in the grade of photoreceptor disruption in
14 eyes of 7 participants for whom longitudinal data were available
and observed increases (5 eyes), decreases (1 eye), and no change
(3 eyes) in the grade of photoreceptor disruption over the follow-upperiod. Interestingly, in 5 eyes both an increase and decrease in the
grade of photoreceptor disruption was observed at different time
points during the study, which may represent dynamic alterations
in the balance between ongoing retinal development and changes
in photoreceptor cell integrity in children with ACHM. An alter-
native explanation is that the differences are artifactual, because
exactly the same foveal cut may not have been obtained on each
longitudinal visit owing to a combination of continuously altering
biometric parameters of the pediatric eye and variations in posi-
tioning of both the child and examiner during scan acquisition
between visits.
To deﬁne the differences between the ACHM and control
groups with regard to retinal layer thickness measurements and
their rate of change over time, linear mixed modelling was per-
formed using STATA (Copyright 1996e2014, StataCorp). Overall
retinal thickness measurements and rate of increase in retinal
thickness with age were reduced signiﬁcantly at the fovea, paraf-
ovea (500 mm from the central fovea), and perifovea (1500 mm
from the central fovea) in ACHM (Fig 2A).
The foveal IRLs were 5 times thicker in ACHM than mean
control values (P < 0.0001), as a result of signiﬁcantly increased
thicknesses of the ganglion cell (GCL), inner plexiform, inner
nuclear (INL), and outer plexiform (OPL) layers. There was an
age-related decrease in foveal IRL thickness in ACHM, owing to
regression of the GCL, INL, and OPL (Fig 2B).
In contrast, the foveal outer retinal layers (ORLs) in ACHM
were signiﬁcantly thinner, being 0.6 times thinner than mean
control values (P < 0.0001), which was attributable to reductions
in the photoreceptor inner segment (IS), outer segment (OS), and
outer nuclear layer (Fig 2C). Foveal IS and OS measurements in
ACHM show a bimodal distribution as a result of the presence
of ISe disruption and/or a hyporeﬂective zone preventing
accurate measurements of the IS and OS in a number of cases
(n ¼ 30; Fig 2F). There was no intergroup difference in the rate
of increase in foveal ORL thickness with age. Mixed
linear regression analysis showed a signiﬁcant negative
correlation between the thickness of the ORLs and the thickness
of the IRLs at the fovea (b ¼ 0.52; P < 0.0001), which
suggests that cone photoreceptors inﬂuence IRL migration during
retinal development.
The perifoveal IRLs were signiﬁcantly thinner in ACHM (P <
0.01; Fig 2B), which was attributable to changes speciﬁcally in the
plexiform layers (Fig 2D, E). It is likely that the lack of input from
normal, functional cone photoreceptors triggers remodeling and
alterations in downstream intraretinal connectivity.
The parafoveal ORLs were uniformly thinner in ACHM at all
ages (P < 0.0001), owing to reductions in IS, OS, and retinal
pigment epithelium (RPE) measurements. Perifoveal ORL thick-
ness in ACHM did not differ from controls at birth. However, after
12 months of age a signiﬁcant intergroup difference emerged, with
thinner perifoveal ORLs in ACHM (Fig 2C). This difference can
be attributed to increasing ORL thickness with age in the
controls, whereas the reverse occurred in ACHM. A contrasting
pattern of changes in the RPE takes place across all measured
retinal locations, where the RPE becomes thinner with age in
ACHM and thicker with age in controls.
We have shown that retinal development is not arrested in
children with ACHM, but is ongoing albeit at a reduced rate and
magnitude in comparison with controls, with consequences for all
retinal layers. We suggest that ACHM is a continuously altering2145
Figure 2. Examples of the developmental trajectories for the retinal thickness (RT), inner retinal layers (IRLs), outer retinal layers (ORLs), inner plexiform
layer (IPL), and outer plexiform layer (OPL) at the fovea and temporal perifovea and the photoreceptor inner segment (IS) and photoreceptor outer segment
(OS) at the fovea. The upper plots for each panel show the trajectories plotted over a time period spanning 0e120 months postnatal age. Each point
represents a single value from each optical coherence tomography (OCT) examination. The lines of best ﬁt (trend lines) are shown in red and blue for the
achromatopsia (ACHM) and control groups, respectively. The lower plots for each panel represent the difference between the best ﬁt lines for ACHM and
control groups (in the upper plots) with the error bars representing the 95% conﬁdence intervals. By calculating partial derivatives of the interaction term
the signiﬁcant differences between ACHM and control groups were estimated at 13 speciﬁed time points, namely, 6, 12, 18, 24, 36, 42, 48, 54, 60, 66, 72,
and 78 months postnatal age. Red colors indicate where there is a signiﬁcantly thinner retinal layer in ACHM and blue colors a signiﬁcantly thicker retinal
layer in ACHM with increasing depth of color representing the level of signiﬁcance.
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Reportsand progressive process in the developing retina. With human gene
therapy trials imminent,5 our results suggest that therapy should be
considered at early ages, while the photoreceptors are still
developing, and thereby potentially facilitating normal retinal
maturation.
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in the Republic of SurinamePrevention of blindness and visual impairment (VI) receives a high
priority in public health programs. To achieve the goals of VISION
2020, regular population-based surveys are crucial to provide an
updated assessment of the visual problems, establish local eye care
programs, and initiate future eye care planning.TheRapidAssessment
of Avoidable Blindness (RAAB) survey is a fast, simple, and inex-
pensive standardizedmethodology to assess the prevalenceand causes
of blindness in people aged50 years in a speciﬁc geographic area.1
The RAAB focuses primarily on the prevalence of avoidable causes
including cataract and uncorrected refractive error.1 Also, cataract
surgical coverage (CSC) can be estimated, indicating the percentage
of people with cataract that have been operated upon.2 Moreover,
RAAB can be used to assess achievements of ongoing intervention
programs over time and make adjustments where necessary.1
The Republic of Suriname is an independent, upper middle-
income country in South America. The country belongs to the
Caribbean, is part of the World Health Organization Americas-B
subregion and is a member of the Pan American Health Organi-
zation.3 Between 1980 and 2012, only 6 nationally representative
studies on the prevalence of blindness and VI were available for
Latin America and the Caribbean and to date no nationally
representative data have been reported for Suriname.4 Therefore,
the aim of this study was to investigate the prevalence and
causes of blindness and VI in Suriname by using the RAAB
methodology, including CSC, cataract surgical outcome, and the
barriers to undergo cataract surgery.
The RAAB survey was carried out between August 2013 and
November 2014 in accordance with the codes of conduct of the
Declaration of Helsinki. Ethical approval for the study was ob-
tained from the Ministry of Health of Suriname. For Suriname, a
sample size of 3000 would provide sufﬁcient power to assess an
expected blindness prevalence of 2.3% among people aged 50
years, with a precision of 32.5%, at 95% conﬁdence, a design
effect of 1.6 and 7% nonresponse. Fifty census enumeration areas
were randomly selected with a probability proportional to the
population in the area. Within each selected enumeration area, 60
residents aged 50 years were selected randomly through compact
segment sampling and examined in their own house using the
standard RAAB protocol.1 Informed written or thumb-printed
consent was obtained from all participants. Presenting distance
visual acuity (VA) was tested using a Snellen tumbling E chart in
full daylight. The primary cause of blindness and VI was assessed
by an ophthalmologist in people with a VA <6/18 in either eye.
Participants with VI owing to cataract in 1 or both eyes were asked
why cataract surgery had not yet been performed. Individuals who
had undergone a cataract operation were asked about details of
their operative procedure. Automated analyses included in the
RAAB software package were used to analyze the data. The CSC2147
